CN120225199A - 口服固体制剂 - Google Patents

口服固体制剂 Download PDF

Info

Publication number
CN120225199A
CN120225199A CN202380078556.XA CN202380078556A CN120225199A CN 120225199 A CN120225199 A CN 120225199A CN 202380078556 A CN202380078556 A CN 202380078556A CN 120225199 A CN120225199 A CN 120225199A
Authority
CN
China
Prior art keywords
oral solid
solid preparation
dissolution test
phenylpyridin
tetrahydronaphthalen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380078556.XA
Other languages
English (en)
Chinese (zh)
Inventor
岛田俊介
川本雅毅
前田泰弘
西村雅裕
由良隆行
古下嵩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of CN120225199A publication Critical patent/CN120225199A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202380078556.XA 2022-11-21 2023-11-20 口服固体制剂 Pending CN120225199A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022185858 2022-11-21
JP2022-185858 2022-11-21
PCT/JP2023/041643 WO2024111552A1 (ja) 2022-11-21 2023-11-20 経口固形製剤

Publications (1)

Publication Number Publication Date
CN120225199A true CN120225199A (zh) 2025-06-27

Family

ID=91195626

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380078556.XA Pending CN120225199A (zh) 2022-11-21 2023-11-20 口服固体制剂

Country Status (4)

Country Link
EP (1) EP4623916A1 (https=)
JP (1) JPWO2024111552A1 (https=)
CN (1) CN120225199A (https=)
WO (1) WO2024111552A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002179571A (ja) * 2000-12-11 2002-06-26 Nikken Chem Co Ltd 小型徐放性錠剤
CA2443632C (en) * 2001-04-10 2011-05-03 Sun Pharmaceutical Industries Limited Timed pulse release composition
WO2002087549A1 (fr) * 2001-04-25 2002-11-07 Taisho Pharmaceutical Co., Ltd. Comprimes a liberation prolongee du type a unites multiples
JP5524624B2 (ja) * 2007-11-16 2014-06-18 旭化成ケミカルズ株式会社 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
JP6186139B2 (ja) * 2013-03-08 2017-08-23 杏林製薬株式会社 口腔内速崩壊性錠剤
JP2017222645A (ja) * 2016-06-10 2017-12-21 大原薬品工業株式会社 腸溶性被覆顆粒の耐酸性が改善された圧縮成形錠剤
KR101907116B1 (ko) * 2016-07-25 2018-10-11 한미약품 주식회사 에스오메프라졸, 또는 약학적으로 허용 가능한 그의 염을 포함하는, pH-의존성 약물 방출 특성이 개선된 제형
ES2992887T3 (en) 2017-04-27 2024-12-19 Mochida Pharm Co Ltd Novel tetrahydronaphthyl urea derivatives as inhibitors of tropomyosin receptor kinase a for the treatment of pain
JP7009288B2 (ja) * 2017-05-18 2022-01-25 エルメッド株式会社 湿製錠剤の製造方法及び湿製錠剤の品質向上方法
WO2019189717A1 (ja) 2018-03-30 2019-10-03 持田製薬株式会社 テトラヒドロナフチルウレア誘導体の製造方法

Also Published As

Publication number Publication date
EP4623916A1 (en) 2025-10-01
JPWO2024111552A1 (https=) 2024-05-30
WO2024111552A1 (ja) 2024-05-30

Similar Documents

Publication Publication Date Title
AU2019280026B2 (en) Galenic formulations of organic compounds
KR101851571B1 (ko) 탁산을 포함하는 무정형 고체 분산체, 그를 포함하는 정제 및 그를 제조하는 방법
US20080160082A1 (en) Controlled release compositions comprising Nimesulide
TWI468191B (zh) 有機化合物之調配物
CN110114063B (zh) 鲁拉西酮固体分散体及其制备方法
CN105073099B (zh) 有机化合物的制剂
WO2015114314A1 (en) Pharmaceutical composition comprising abiraterone
CN113645962A (zh) 含有富马酸二甲酯的肠溶片剂
EP1738754B1 (en) Solid pharmaceutical preparation
WO2015145145A1 (en) Pharmaceutical composition comprising lapatinib
WO2015145157A1 (en) Pharmaceutical composition comprising pazopanib
JP2023509560A (ja) 高いバイオアベイラビリティを有するソラフェニブの医薬組成物及びその応用
CA3245018A1 (en) THERAPEUTIC COMPOUNDS, FORMULATIONS AND THEIR USE
TWI784575B (zh) 一種複合物的藥物組合物及其製備方法
JP5805891B2 (ja) ５−ヒドロキシ−１ｈ−イミダゾール−４−カルボキサミドを含有する錠剤
CN120225199A (zh) 口服固体制剂
US20220016058A1 (en) Pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and preparation method therefor
WO2025144120A1 (en) Multi-layer pharmaceutical formulation of mirabegron and solifenacin succinate
US10898488B2 (en) Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
US20210346303A1 (en) Coating method
WO2026064392A1 (en) Fixed dose combination of flavoxate and beta-3 adrenergic receptor agonists, and formulations and manufacturing processes thereof
Rahman Domperidone: A literature based review on pharmacokinetic control using different drug delivery strategies
CN110577475A (zh) 一种氨溴索衍生物及其制方、药物组合物与用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination